1,5-benzothiazepine

Networked: 6 relevant articles (1 outcomes, 0 trials/studies)

1.	Cardiovascular Diseases (Cardiovascular Disease) 04/01/1991 - "Diltiazem, a 1,5-benzothiazepine, has demonstrated efficacy in the treatment of numerous cardiovascular diseases. "
2.	Hypertension (High Blood Pressure) 04/01/1988 - "The hypotensive effect of a new 1,5-benzothiazepine derivative, TA-3090 ((+) (2S,3S)-3-acetoxy-8-chloro-5-(2-(dimethylamino)ethyl)-2, 3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one maleate), was studied in various models of experimental hypertension. " 11/01/2008 - "Successful introduction of diltiazem and clentiazem for angina pectoris, hypertension, arrhythmias and other related cardiac disorders proved potential of 1,5-benzothiazepine moiety. "
3.	Stroke (Strokes) 06/01/1992 - "Prophylactic effects of a new 1,5-benzothiazepine calcium antagonist on stroke in salt-loaded stroke-prone spontaneously hypertensive rats."
4.	Thrombosis (Thrombus) 03/01/1998 - "Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis."
5.	Cardiomyopathies (Cardiomyopathy) 07/01/1993 - "We investigated the effects of clentiazem, a 1,5-benzothiazepine calcium antagonist, on epinephrine-induced cardiomyopathy in rats. "